£890.00

The 2027-2032 World Outlook for Interleukin Blockers for Psoriasis Treatments

Price data last checked 17 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£890 today · cheaper than every other day in the last 2 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days · 35 data points (no recent data)

Historical
Generating forecast…
£890.00 £845.50 £863.30 £881.10 £898.90 £916.70 £934.50 27 July 2026 04 August 2026 13 August 2026 21 August 2026 30 August 2026

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price
35 days 0 9 18 26 35 £890 Days at Price

Price Analysis

Most common price: £890 (35 days, 100.0%)

Price range: £890 - £890

Price levels: 1 different prices over 35 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
05 January 2026
Listed Since
12 February 2026

Similar Products You Might Like

The 2027-2032 World Outlook for Interleukin Inhibitors
96% match

The 2027-2032 World Outlook for Interleukin Inhibitors

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Topical Vitiligo Therapeutics
95% match

The 2027-2032 World Outlook for Topical Vitiligo Therapeutics

£890.00 12 Aug 2026
The 2027-2032 World Outlook for Dyslipidemia Therapeutics
95% match

The 2027-2032 World Outlook for Dyslipidemia Therapeutics

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Oligonucleotide Therapeutics
95% match

The 2027-2032 World Outlook for Oligonucleotide Therapeutics

£890.00 30 Aug 2026
The 2027-2032 World Outlook for Clostridium Difficile Infection Treatments
95% match

The 2027-2032 World Outlook for Clostridium Difficile Infection Treatments

£890.00 05 Aug 2026
The 2027-2032 World Outlook for Lysosomal Storage Diseases Treatments
94% match

The 2027-2032 World Outlook for Lysosomal Storage Diseases Treatments

£890.00 29 Aug 2026
The 2027-2032 World Outlook for Lysosomal Storage Diseases Therapeutics
94% match

The 2027-2032 World Outlook for Lysosomal Storage Diseases Therapeutics

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Kinase Inhibitors
94% match

The 2027-2032 World Outlook for Kinase Inhibitors

£890.00 29 Aug 2026
The 2027-2032 World Outlook for Kinase Inhibitor Drugs
94% match

The 2027-2032 World Outlook for Kinase Inhibitor Drugs

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics
94% match

The 2027-2032 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics

£890.00 31 Aug 2026
The 2027-2032 World Outlook for Drugs for Rheumatoid Arthritis
94% match

The 2027-2032 World Outlook for Drugs for Rheumatoid Arthritis

£890.00 13 Aug 2026
The 2027-2032 World Outlook for Hydroxychloroquine Sulphates
94% match

The 2027-2032 World Outlook for Hydroxychloroquine Sulphates

£890.00 07 Jul 2026
The 2027-2032 World Outlook for Diaper Rash Treatment Products
94% match

The 2027-2032 World Outlook for Diaper Rash Treatment Products

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Oligonucleotide Therapeutics for Neurological Disorders
94% match

The 2027-2032 World Outlook for Oligonucleotide Therapeutics for Neurological Disorders

£890.00 04 Aug 2026
The 2027-2032 World Outlook for HIV Therapeutics
94% match

The 2027-2032 World Outlook for HIV Therapeutics

£890.00 30 Jul 2026
The 2027-2032 World Outlook for Biosurfactants
94% match

The 2027-2032 World Outlook for Biosurfactants

£890.00 29 Aug 2026
The 2027-2032 World Outlook for Somatostatin Analogs Treatments
94% match

The 2027-2032 World Outlook for Somatostatin Analogs Treatments

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Combination Antibody Therapies
94% match

The 2027-2032 World Outlook for Combination Antibody Therapies

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Particulate Vaccine Adjuvants
94% match

The 2027-2032 World Outlook for Particulate Vaccine Adjuvants

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Chronic Obstructive Pulmonary Disease Treatments
94% match

The 2027-2032 World Outlook for Chronic Obstructive Pulmonary Disease Treatments

£890.00 30 Jul 2026
The 2027-2032 World Outlook for Menopausal Hot Flashes Therapies
94% match

The 2027-2032 World Outlook for Menopausal Hot Flashes Therapies

£890.00 08 Aug 2026
The 2027-2032 World Outlook for Blood and Tissue Interferon Growth Factors
94% match

The 2027-2032 World Outlook for Blood and Tissue Interferon Growth Factors

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Vaccine Adjuvants
94% match

The 2027-2032 World Outlook for Vaccine Adjuvants

£890.00 04 Aug 2026
The 2027-2032 World Outlook for Biotherapeutics Cell Line Developments
94% match

The 2027-2032 World Outlook for Biotherapeutics Cell Line Developments

£890.00 29 Jul 2026